ALIPAY+
16.12.2022 05:08:36 CET | Business Wire | Press release
Alipay+, the provider of global cross-border digital payments and marketing solutions, today rolled out its first year-end promotion campaign with merchants across Asia and Europe, in collaboration with five Asian e-wallet partners - AlipayHK (Hong Kong SAR, China), GCash (Philippines), Kakao Pay (South Korea), TrueMoney (Thailand) and Touch ‘n Go eWallet (Malaysia).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215006131/en/
Great in-destination merchant offers are available where Alipay+ operates, including Japan, South Korea, Singapore and various countries in Europe. (Graphic: Business Wire)
The promotion campaign sees the participation of over one million merchants in retail, F&B, tourist attractions and hospitality across major travel destinations where Alipay+ is accepted, including Japan, South Korea, Singapore, and various countries in Europe. During the campaign period, users of participating e-wallets can enjoy a wide range of deals offered by Alipay+ together with merchant partners in each destination.
Leveraging the Alipay+ marketing solutions, merchants are able to create and customize promotions in the forms of either digital coupons or instant discounts. Merchants can also distribute digital coupons in multiple e-wallet apps at the same time to achieve better marketing efficiency and scalability.
Japan
Between 15 December 2022 and 15 February 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will receive three coupons in their respective apps upon arrival in Japan. Each of the three coupons offers a ¥50 discount with a minimum of ¥51 spent, and can be redeemed at all local merchants accepting Alipay+ payments across Japan.
In addition, Alipay+ has also introduced other merchant-specific coupons. Such offers include, but are not limited to:
- ¥1,000 OFF with a minimum of ¥5,000 spent at merchants such as Daimaru Department Store, Keio Department Store, Kintetsu Department Store, merchants at Fukuoka Airport, BicCamera stores, and many others.
- ¥500 OFF with a minimum of ¥3,000 spent at merchants such as Tsuruha Drug Store, Sapporo Drug Store, and many others.
E-wallet users are able to access and browse all merchant-specific coupons in their respective apps.
Through the integration of Alipay+ solutions, over one million brick-and-mortar merchants in Japan including airports, shopping malls, convenience stores, cafes, and restaurants are now able to accept various mobile payment methods.
South Korea
From now till the end of December, users of AlipayHK, GCash, TrueMoney and Touch ‘n Go eWallet can redeem digital coupons by simply using the respective e-wallets to scan the Alipay+ in-store promotion QR code displayed at the store cashiers, and enjoy instant discounts of up to 10%, when they pay with their e-wallets via Alipay+ at local merchants.
Participating merchants include F&B brands like Paris Baguette, Haidilao, retailers such as Daiso, Galleria Department Store, as well as Lotte Duty Free, Shinsegae Duty Free, etc. Over 120,000 merchants in South Korea are now accept the payments made by these four e-wallets via Alipay+.
Singapore
From now till 31 January 2023, users of AlipayHK, GCash, Kakao Pay, TrueMoney and Touch ’n Go eWallet will be given three coupons upon arrival in Singapore and enjoy savings when shopping in Singapore.
- Coupon 1: SGD 1 off with a minimum of SGD 1.01 spent
- Coupon 2: SGD 3 off with a minimum of SGD 3.01 spent
- Coupon 3: SGD 8 off with a minimum of SGD 100 spent
Furthermore, Alipay+ has extended more promotions with various merchants at Changi Airport and Paragon Shopping Centre. Between 15 December 2022 and 31 January 2023, e-wallet users can enjoy three more deals:
- Coupon 1: SGD 5 off with a minimum of SGD 20 spent;
- Coupon 2: SGD 10 off with a minimum of SGD 100 spent;
- Coupon 3: SGD 18 off with a minimum of SGD 200 spent.
When taking a ComfortDelgro Taxi in Singapore, users can also claim SGD 2 off with a minimum spending of SGD 2.01.
Each e-wallet user can redeem up to three coupons during the campaign period.
Europe
In France, UK, Italy and Germany, Alipay+ has rolled out various promotions and deals with local merchants, including retail stores Printemps in France and city-wide vending machines in Milan, Rome and Venice to reward shoppers this holiday season.
Between now and 31 January 2023, users of Kakao Pay, GCash, TrueMoney and Touch ‘n Go eWallet can enjoy up to 10 EUR in instant discounts when paying with the respective e-wallets at the aforementioned merchants. In addition, Printemps in France is also offering e-wallet users a special 5% store-wide discount and a free bubble tea voucher at the Printemps Haussmann store. E-wallet users can visit the store information desks to check for specific details.
As of November 2022, Alipay+’s merchant coverage has reached 2.5 million. Its merchant network includes regional and global digital entertainment providers, lifestyle services, e-commerce platforms and a wide range of brick-and-mortar businesses that cover major airports, shopping centers, duty free shops, convenience stores, cafes, restaurants and tourism facilities.
The global merchant coverage of Alipay+ by sector includes over 1,000 online platforms, more than 10 major airports, over 90,000 convenience stores, over 360,000 restaurants, nearly 200,000 taxis and major hotel brands, department stores, duty-free shops and tourist facilities in Asia and Europe.
*Terms and conditions apply in coupon usage and redemption.
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221215006131/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
